BioCentury | May 25, 2018
Company News

Takeda divests stake in Chinese JV Techpool

...protease to treat stroke. Takeda gained its stake in Techpool through its 2011 acquisition of Nycomed...
BioCentury | May 23, 2018
Company News

Takeda divests stake in Chinese JV

...protease to treat stroke. Takeda gained its stake in Techpool through its 2011 acquisition of Nycomed...
BioCentury | May 11, 2018
Company News

Shire acquisition to give Takeda new global footprint

...3%. Takeda gained much of its existing emerging markets infrastructure through the 2011 acquisition of Nycomed...
BioCentury | May 8, 2018
Company News

Shire deal to rebalance Takeda's global footprint

...3%. Takeda gained much of its existing emerging markets infrastructure through the 2011 acquisition of Nycomed...
BioCentury | Apr 20, 2018
Company News

Shire rejects third Takeda bid, as Allergan drops out

...discussions are ongoing. Takeda's largest previous takeout was its €9.6 billion ($12.9 billion) acquisition of Nycomed...
BioCentury | Apr 20, 2018
Company News

Shire rejects third Takeda bid, mulling fourth

...a 51% stake. Takeda's largest previous takeout was its €9.6 billion ($12.9 billion) acquisition of Nycomed...
BioCentury | Mar 30, 2018
Company News

Takeda mulls Shire takeover

...for Shire would dwarf Takeda's largest previous takeout, its €9.6 billion ($12.9 billion) acquisition of Nycomed...
BioCentury | Mar 28, 2018
Company News

Shire posts big gain as Takeda mulls takeover

...for Shire would dwarf Takeda's largest previous takeout, its €9.6 billion ($12.9 billion) acquisition of Nycomed...
BioCentury | May 30, 2016
Strategy

Taking Takeda global

...emerging markets. Takeda gained much of its emerging markets infrastructure through the 2011 acquisition of Nycomed...
BioCentury | Feb 23, 2015
Clinical News

Daliresp roflumilast: Phase III/IV data

...treat severe COPD associated with chronic bronchitis. Takeda gained Daxas through its 2011 acquisition of Nycomed...
Items per page:
1 - 10 of 576
BioCentury | May 25, 2018
Company News

Takeda divests stake in Chinese JV Techpool

...protease to treat stroke. Takeda gained its stake in Techpool through its 2011 acquisition of Nycomed...
BioCentury | May 23, 2018
Company News

Takeda divests stake in Chinese JV

...protease to treat stroke. Takeda gained its stake in Techpool through its 2011 acquisition of Nycomed...
BioCentury | May 11, 2018
Company News

Shire acquisition to give Takeda new global footprint

...3%. Takeda gained much of its existing emerging markets infrastructure through the 2011 acquisition of Nycomed...
BioCentury | May 8, 2018
Company News

Shire deal to rebalance Takeda's global footprint

...3%. Takeda gained much of its existing emerging markets infrastructure through the 2011 acquisition of Nycomed...
BioCentury | Apr 20, 2018
Company News

Shire rejects third Takeda bid, as Allergan drops out

...discussions are ongoing. Takeda's largest previous takeout was its €9.6 billion ($12.9 billion) acquisition of Nycomed...
BioCentury | Apr 20, 2018
Company News

Shire rejects third Takeda bid, mulling fourth

...a 51% stake. Takeda's largest previous takeout was its €9.6 billion ($12.9 billion) acquisition of Nycomed...
BioCentury | Mar 30, 2018
Company News

Takeda mulls Shire takeover

...for Shire would dwarf Takeda's largest previous takeout, its €9.6 billion ($12.9 billion) acquisition of Nycomed...
BioCentury | Mar 28, 2018
Company News

Shire posts big gain as Takeda mulls takeover

...for Shire would dwarf Takeda's largest previous takeout, its €9.6 billion ($12.9 billion) acquisition of Nycomed...
BioCentury | May 30, 2016
Strategy

Taking Takeda global

...emerging markets. Takeda gained much of its emerging markets infrastructure through the 2011 acquisition of Nycomed...
BioCentury | Feb 23, 2015
Clinical News

Daliresp roflumilast: Phase III/IV data

...treat severe COPD associated with chronic bronchitis. Takeda gained Daxas through its 2011 acquisition of Nycomed...
Items per page:
1 - 10 of 576